Beximco Pharmaceuticals Limited (DSE: BXPHARMA)

Beximco Pharmaceuticals Revenue

Beximco Pharmaceuticals had revenue of 10.99B BDT in the quarter ending March 31, 2024, with 15.00% growth. This brings the company's revenue in the last twelve months to 43.08B, up 13.46% year-over-year. In the fiscal year ending June 30, 2023, Beximco Pharmaceuticals had annual revenue of 39.27B with 13.26% growth.

• Revenue (ttm): 43.08B
• Revenue Growth: +13.46%
• P/S Ratio: 0.79
• Revenue / Employee: 7.56M
• Employees: 5,700
• Market Cap: 34.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	39.27B	4.60B	13.26%
Jun 30, 2022	34.67B	5.18B	17.55%
Jun 30, 2021	29.49B	3.88B	15.16%
Jun 30, 2020	25.61B	2.80B	12.25%
Jun 30, 2019	22.82B	5.10B	28.79%